Daridorexant and Rifampicin (Rifcap 300 mg Kapsül): interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Strong or moderate CYP3A4 induction reduces daridorexant exposure.
Clinical significance and safety
Rifampin can reduce daridorexant exposure and its effect on insomnia. The daridorexant label advises avoiding strong or moderate CYP3A4 inducers. Increasing sleep medicine without a prescriber is not an appropriate response to reduced efficacy.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.